BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chakravarty T, Makkar RR, Ascheim DD, Traverse JH, Schatz R, DeMaria A, Francis GS, Povsic TJ, Smith RR, Lima JA, Pogoda JM, Marbán L, Henry TD. ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) Trial: Rationale and Design. Cell Transplant 2017;26:205-14. [PMID: 27543900 DOI: 10.3727/096368916X692933] [Cited by in Crossref: 53] [Cited by in F6Publishing: 33] [Article Influence: 8.8] [Reference Citation Analysis]
Number Citing Articles
1 Iop L, Palmosi T, Dal Sasso E, Gerosa G. Bioengineered tissue solutions for repair, correction and reconstruction in cardiovascular surgery. J Thorac Dis 2018;10:S2390-411. [PMID: 30123578 DOI: 10.21037/jtd.2018.04.27] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
2 Singh S, Chakravarty T, Chen P, Akhmerov A, Falk J, Friedman O, Zaman T, Ebinger JE, Gheorghiu M, Marbán L, Marbán E, Makkar RR. Allogeneic cardiosphere-derived cells (CAP-1002) in critically ill COVID-19 patients: compassionate-use case series. Basic Res Cardiol 2020;115:36. [PMID: 32399655 DOI: 10.1007/s00395-020-0795-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
3 Rosen MR, Myerburg RJ, Francis DP, Cole GD, Marbán E. Translating stem cell research to cardiac disease therapies: pitfalls and prospects for improvement. J Am Coll Cardiol 2014;64:922-37. [PMID: 25169179 DOI: 10.1016/j.jacc.2014.06.1175] [Cited by in Crossref: 65] [Cited by in F6Publishing: 54] [Article Influence: 8.1] [Reference Citation Analysis]
4 Grigorian-Shamagian L, Fereydooni S, Liu W, Echavez A, Marbán E. Harnessing the heart's resistance to malignant tumors: cardiac-derived extracellular vesicles decrease fibrosarcoma growth and leukemia-related mortality in rodents. Oncotarget 2017;8:99624-36. [PMID: 29245929 DOI: 10.18632/oncotarget.20454] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
5 Turner D, Rieger AC, Balkan W, Hare JM. Clinical-based Cell Therapies for Heart Disease-Current and Future State. Rambam Maimonides Med J. 2020;11. [PMID: 32374254 DOI: 10.5041/rmmj.10401] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Liu S, Jiang Z, Qiao L, Guo B, Xiao W, Zhang X, Chang L, Li Y. Integrin β-3 is required for the attachment, retention and therapeutic benefits of human cardiospheres in myocardial infarction. J Cell Mol Med 2018;22:382-9. [PMID: 29024385 DOI: 10.1111/jcmm.13325] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
7 Bolli R, Tang XL. Clinical trials of cell therapy for heart failure: recent results warrant continued research. Curr Opin Cardiol 2022;37:193-200. [PMID: 35612934 DOI: 10.1097/HCO.0000000000000956] [Reference Citation Analysis]
8 Madigan M, Atoui R. Therapeutic Use of Stem Cells for Myocardial Infarction. Bioengineering (Basel) 2018;5:E28. [PMID: 29642402 DOI: 10.3390/bioengineering5020028] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
9 Shoja-Taheri F, George A, Agarwal U, Platt MO, Gibson G, Davis ME. Using Statistical Modeling to Understand and Predict Pediatric Stem Cell Function. Circ Genom Precis Med 2019;12:e002403. [PMID: 31100989 DOI: 10.1161/CIRCGEN.118.002403] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Povsic TJ, Gersh BJ. Stem Cells in Cardiovascular Diseases: 30,000-Foot View. Cells 2021;10:600. [PMID: 33803227 DOI: 10.3390/cells10030600] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Polhemus DJ, Trivedi RK, Sharp TE, Li Z, Goodchild TT, Scarborough A, de Couto G, Marbán E, Lefer DJ. Repeated cell transplantation and adjunct renal denervation in ischemic heart failure: exploring modalities for improving cell therapy efficacy. Basic Res Cardiol 2019;114:9. [PMID: 30656501 DOI: 10.1007/s00395-019-0718-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
12 Bittle GJ, Morales D, Deatrick KB, Parchment N, Saha P, Mishra R, Sharma S, Pietris N, Vasilenko A, Bor C, Ambastha C, Gunasekaran M, Li D, Kaushal S. Stem Cell Therapy for Hypoplastic Left Heart Syndrome: Mechanism, Clinical Application, and Future Directions. Circ Res 2018;123:288-300. [PMID: 29976693 DOI: 10.1161/CIRCRESAHA.117.311206] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 7.3] [Reference Citation Analysis]
13 Winkler J, Lukovic D, Mester-Tonczar J, Zlabinger K, Gugerell A, Pavo N, Jakab A, Szankai Z, Traxler D, Müller C, Spannbauer A, Riesenhuber M, Hašimbegović E, Dawkins J, Zimmermann M, Ankersmit HJ, Marbán E, Gyöngyösi M. Quantitative Hybrid Cardiac [18F]FDG-PET-MRI Images for Assessment of Cardiac Repair by Preconditioned Cardiosphere-Derived Cells. Mol Ther Methods Clin Dev 2020;18:354-66. [PMID: 32671138 DOI: 10.1016/j.omtm.2020.06.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Gallet R, Dawkins J, Valle J, Simsolo E, de Couto G, Middleton R, Tseliou E, Luthringer D, Kreke M, Smith RR, Marbán L, Ghaleh B, Marbán E. Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction. Eur Heart J 2017;38:201-11. [PMID: 28158410 DOI: 10.1093/eurheartj/ehw240] [Cited by in Crossref: 97] [Cited by in F6Publishing: 196] [Article Influence: 24.3] [Reference Citation Analysis]
15 Beez CM, Haag M, Klein O, Van Linthout S, Sittinger M, Seifert M. Extracellular vesicles from regenerative human cardiac cells act as potent immune modulators by priming monocytes. J Nanobiotechnology 2019;17:72. [PMID: 31133024 DOI: 10.1186/s12951-019-0504-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
16 Davidson SM, Yellon DM. Exosomes and cardioprotection - A critical analysis. Mol Aspects Med. 2018;60:104-114. [PMID: 29122678 DOI: 10.1016/j.mam.2017.11.004] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 10.4] [Reference Citation Analysis]
17 Ontoria-Oviedo I, Palacios I, Panadero J, Sánchez B, García-García F, López-Cerdán A, Dorronsoro A, Castellano D, Rodríguez-Borlado L, Bernad A, Sepúlveda P. Plasmatic Membrane Expression of Adhesion Molecules in Human Cardiac Progenitor/Stem Cells Might Explain Their Superior Cell Engraftment after Cell Transplantation. Stem Cells Int 2020;2020:8872009. [PMID: 33101423 DOI: 10.1155/2020/8872009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Carresi C, Scicchitano M, Scarano F, Macrì R, Bosco F, Nucera S, Ruga S, Zito MC, Mollace R, Guarnieri L, Coppoletta AR, Gliozzi M, Musolino V, Maiuolo J, Palma E, Mollace V. The Potential Properties of Natural Compounds in Cardiac Stem Cell Activation: Their Role in Myocardial Regeneration. Nutrients 2021;13:275. [PMID: 33477916 DOI: 10.3390/nu13010275] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Malliaras K, Smith RR, Kanazawa H, Yee K, Seinfeld J, Tseliou E, Dawkins JF, Kreke M, Cheng K, Luthringer D. Validation of contrast-enhanced magnetic resonance imaging to monitor regenerative efficacy after cell therapy in a porcine model of convalescent myocardial infarction. Circulation. 2013;128:2764-2775. [PMID: 24061088 DOI: 10.1161/circulationaha.113.002863] [Cited by in Crossref: 80] [Cited by in F6Publishing: 50] [Article Influence: 8.9] [Reference Citation Analysis]
20 Malliaras K, Makkar RR, Smith RR, Cheng K, Wu E, Bonow RO, Marbán L, Mendizabal A, Cingolani E, Johnston PV, Gerstenblith G, Schuleri KH, Lardo AC, Marbán E. Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction). J Am Coll Cardiol 2014;63:110-22. [PMID: 24036024 DOI: 10.1016/j.jacc.2013.08.724] [Cited by in Crossref: 328] [Cited by in F6Publishing: 301] [Article Influence: 36.4] [Reference Citation Analysis]
21 Maxwell JT, Trac D, Shen M, Brown ME, Davis ME, Chao MS, Supapannachart KJ, Zaladonis CA, Baker E, Li ML, Zhao J, Jacobs DI. Electrical Stimulation of pediatric cardiac-derived c-kit+ progenitor cells improves retention and cardiac function in right ventricular heart failure. Stem Cells 2019;37:1528-41. [PMID: 31574184 DOI: 10.1002/stem.3088] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Mathur A, Fernández-Avilés F, Dimmeler S, Hauskeller C, Janssens S, Menasche P, Wojakowski W, Martin JF, Zeiher A; BAMI Investigators. The consensus of the Task Force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure: update 2016. Eur Heart J 2017;38:2930-5. [PMID: 28204458 DOI: 10.1093/eurheartj/ehw640] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 15.0] [Reference Citation Analysis]
23 Crisostomo V, Baez C, Abad JL, Sanchez B, Alvarez V, Rosado R, Gómez-Mauricio G, Gheysens O, Blanco-Blazquez V, Blazquez R, Torán JL, Casado JG, Aguilar S, Janssens S, Sánchez-Margallo FM, Rodriguez-Borlado L, Bernad A, Palacios I. Dose-dependent improvement of cardiac function in a swine model of acute myocardial infarction after intracoronary administration of allogeneic heart-derived cells. Stem Cell Res Ther 2019;10:152. [PMID: 31151405 DOI: 10.1186/s13287-019-1237-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
24 Pagano F, Picchio V, Chimenti I, Sordano A, De Falco E, Peruzzi M, Miraldi F, Cavarretta E, Zoccai GB, Sciarretta S, Frati G, Marullo AGM. On the Road to Regeneration: "Tools" and "Routes" Towards Efficient Cardiac Cell Therapy for Ischemic Cardiomyopathy. Curr Cardiol Rep 2019;21:133. [PMID: 31673821 DOI: 10.1007/s11886-019-1226-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
25 Maghin E, Garbati P, Quarto R, Piccoli M, Bollini S. Young at Heart: Combining Strategies to Rejuvenate Endogenous Mechanisms of Cardiac Repair. Front Bioeng Biotechnol 2020;8:447. [PMID: 32478060 DOI: 10.3389/fbioe.2020.00447] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
26 Collantes M, Pelacho B, García-Velloso MJ, Gavira JJ, Abizanda G, Palacios I, Rodriguez-Borlado L, Álvarez V, Prieto E, Ecay M, Larequi E, Peñuelas I, Prósper F. Non-invasive in vivo imaging of cardiac stem/progenitor cell biodistribution and retention after intracoronary and intramyocardial delivery in a swine model of chronic ischemia reperfusion injury. J Transl Med 2017;15:56. [PMID: 28288654 DOI: 10.1186/s12967-017-1157-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
27 Nakamura K, Murry CE. Function Follows Form - A Review of Cardiac Cell Therapy. Circ J. 2019;83:2399-2412. [PMID: 31723070 DOI: 10.1253/circj.cj-19-0567] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
28 Gallet R, Tseliou E, Dawkins J, Middleton R, Valle J, Angert D, Reich H, Luthringer D, Kreke M, Smith R, Marbán L, Marbán E. Intracoronary delivery of self-assembling heart-derived microtissues (cardiospheres) for prevention of adverse remodeling in a pig model of convalescent myocardial infarction. Circ Cardiovasc Interv 2015;8:e002391. [PMID: 25953823 DOI: 10.1161/CIRCINTERVENTIONS.115.002391] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
29 Ambastha C, Bittle GJ, Morales D, Parchment N, Saha P, Mishra R, Sharma S, Vasilenko A, Gunasekaran M, Al-Suqi MT, Li D, Yang P, Kaushal S. Regenerative medicine therapy for single ventricle congenital heart disease. Transl Pediatr 2018;7:176-87. [PMID: 29770299 DOI: 10.21037/tp.2018.04.01] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
30 Hao M, Wang R, Wang W. Cell Therapies in Cardiomyopathy: Current Status of Clinical Trials. Anal Cell Pathol (Amst) 2017;2017:9404057. [PMID: 28194324 DOI: 10.1155/2017/9404057] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
31 Mauretti A, Spaans S, Bax NAM, Sahlgren C, Bouten CVC. Cardiac Progenitor Cells and the Interplay with Their Microenvironment. Stem Cells Int 2017;2017:7471582. [PMID: 29075298 DOI: 10.1155/2017/7471582] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
32 Lefer DJ, Marbán E. Is Cardioprotection Dead? Circulation 2017;136:98-109. [PMID: 28674094 DOI: 10.1161/CIRCULATIONAHA.116.027039] [Cited by in Crossref: 38] [Cited by in F6Publishing: 22] [Article Influence: 7.6] [Reference Citation Analysis]
33 Yousefi-ahmadipour A, Asadi F, Pirsadeghi A, Nazeri N, Vahidi R, Abazari MF, Afgar A, Mirzaei-parsa MJ. Current Status of Stem Cell Therapy and Nanofibrous Scaffolds in Cardiovascular Tissue Engineering. Regen Eng Transl Med . [DOI: 10.1007/s40883-021-00230-1] [Reference Citation Analysis]
34 Ostovaneh MR, Makkar RR, Ambale-Venkatesh B, Ascheim D, Chakravarty T, Henry TD, Kowalchuk G, Aguirre FV, Kereiakes DJ, Povsic TJ, Schatz R, Traverse JH, Pogoda J, Smith RD, Marbán L, Marbán E, Lima JAC. Effect of cardiosphere-derived cells on segmental myocardial function after myocardial infarction: ALLSTAR randomised clinical trial. Open Heart 2021;8:e001614. [PMID: 34233913 DOI: 10.1136/openhrt-2021-001614] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Di Mauro M, Ghinassi B, Di Baldassarre A. Commentary: I fix what's broken-including the heart. J Thorac Cardiovasc Surg 2020:S0022-5223(20)31766-9. [PMID: 33246566 DOI: 10.1016/j.jtcvs.2020.05.116] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Loisel F, Provost B, Haddad F, Guihaire J, Amsallem M, Vrtovec B, Fadel E, Uzan G, Mercier O. Stem cell therapy targeting the right ventricle in pulmonary arterial hypertension: is it a potential avenue of therapy? Pulm Circ 2018;8:2045893218755979. [PMID: 29480154 DOI: 10.1177/2045893218755979] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]